Breaking News Instant updates and real-time market news.

ICPT

Intercept

$128.45

-0.05 (-0.04%)

, CBAY

CymaBay

$5.65

-0.15 (-2.59%)

10:21
07/17/17
07/17
10:21
07/17/17
10:21

Intercept slides as analyst calls CymaBay drug 'true contender' after data

Shares of Intercept Pharmaceuticals (ICPT) are sliding after H.C. Wainwright analyst Ed Arce raised his price target for its competitor CymaBay Therapeutics (CBAY) following data from the company's Phase 2 study of seladelpar in primary biliary cholangitis. The analyst argued that the latter's results "are more robust" than Intercept's Ocaliva. STUDY RESULTS: CymaBay has announced interim results from its ongoing low-dose Phase 2 study of seladelpar in patients with primary biliary cholangitis, or PBC, a life-threatening and life-limiting chronic cholestatic liver disease. A planned interim analysis of the first 24 patients enrolled in the 5 mg or 10mg dose groups demonstrated after 12 weeks of treatment a significant alkaline phosphatase, or AP, reduction from baseline of 39% and 45%, respectively. On seladelpar, 45% of patients in the 5mg and 82% of patients in the 10 mg dose groups had AP values less than 1.67 times the upper limit of normal, or ULN. There were no serious adverse events and no safety transaminase signal was observed at either dose, said the company, which added that, consistent with prior studies, there was no signal for drug-induced pruritus. After sharing preliminary results from the study, the Food and Drug Administration has agreed to allow continuation of seladelpar treatment beyond six months for the 5 mg and 10 mg doses. 'TRUE CONTENDER' TO OCALIVA: In a research note this morning, H.C. Wainwright's Arce raised his price target for CymaBay to $12 from $7 following the report of the 12-week Phase 2 results of its seladelpar, citing increased confidence in the drug's approvability and market potential. The analyst noted that he views CymaBay's results as "favorable" to those of Intercept Pharmaceutical's Ocaliva 10mg and believes it likely that seladelpar's efficacy grows stronger over time. Arce also added that he sees seladelpar as a "true contender" to Intercept's Ocaliva as the former's Phase 2 primary biliary cholangitis results "are most robust." He reiterated a Buy rating on Cymabay. PRICE ACTION: In morning trading, shares of Intercept Pharmaceuticals have dropped over 1% to $126.93, while CymaBay Therapeutics' stock has jumped almost 20% to $6.74.

ICPT

Intercept

$128.45

-0.05 (-0.04%)

CBAY

CymaBay

$5.65

-0.15 (-2.59%)

  • 17

    Jul

ICPT Intercept
$128.45

-0.05 (-0.04%)

02/24/17
BMOC
02/24/17
NO CHANGE
BMOC
Intercept price target raised to $221 from $198 at BMO Capital
BMO Capital analyst M. Ian Somaiya raised his price target on Intercept as he believes that updated launch metrics on the company's Ocaliva drug suggest that 2017 sales of the product will exceed expectations. He keeps an Outperform rating on the stock.
02/28/17
SBSH
02/28/17
NO CHANGE
Target $240
SBSH
Buy
Intercept price target lowered to $240 from $275 at Citi
Citi analyst Joel Beatty lowered his price target for Intercept Pharmaceuticals to $240 citing less upside potential over the next year with REGENERATE trial results still likely at least two years away. The analyst reiterates a Buy rating on Intercept, however, saying investors should get more comfortable that NASH is a "sizeable drug opportunity" as development of OCA and other NASH drugs advance.
05/05/17
LDLW
05/05/17
UPGRADE
LDLW
Hold
Intercept upgraded to Hold from Sell at Laidlaw
07/17/17
HCWC
07/17/17
NO CHANGE
Target $12
HCWC
Buy
CymaBay price target raised to $12 from $7 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for CymaBay (CBAY) to $12 saying the Phase 2 results of seladelpar in primary biliary cholangitis "are more robust" than Intercept Pharmaceutical's (ICPT) Ocaliva. The analyst notes that his new target reflects increased confidence in the approvability and market potential of seladelpar. He has a Buy rating on CymaBay.
CBAY CymaBay
$5.65

-0.15 (-2.59%)

01/30/17
HCWC
01/30/17
UPGRADE
Target $6
HCWC
Buy
CymaBay upgraded to Buy from Neutral at H.C. Wainwright
H.C. Wainwright analyst Ed Arce upgraded CymaBay to Buy citing the potential for up to $200M of milestone payments from Kowa, the company's new U.S. partner for arhalofenate, and a more positive view of the potential of MBX-8025 to treat Primary Biliary Cirrhosis. The analyst raised his price target for the shares to $6 from $2.50.
03/24/17
ROTH
03/24/17
NO CHANGE
Target $6
ROTH
Buy
CymaBay recent pull back represents 'attractive entry point,' says Roth Capital
Roth Capital analyst Sa'ar Yaniv notes that CymaBay expects that data from two arms of the ongoing, second Phase 2 study of seladelpar in primary biliary cholangitis will be released in Q3, and data from the third arm will be available by YE17. The analyst believes that shares continue to trade up in front of the data, and with recent pull back, the current price represents an "attractive entry point." He reiterates a Buy rating and $6 price target on the shares.
06/22/17
OPCO
06/22/17
INITIATION
Target $8
OPCO
Outperform
CymaBay initiated with an Outperform at Oppenheimer
Oppenheimer analyst Jay Olson started CymaBay with an Outperform rating and $8 price target.

TODAY'S FREE FLY STORIES

CTL

CenturyLink

$23.37

0.15 (0.65%)

12:35
07/22/17
07/22
12:35
07/22/17
12:35
Periodicals
CenturyLink CEO disagrees with Minnesota Attorney General claims, Reuters says »

CenturyLink CEO Glen Post…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

DB

Deutsche Bank

$18.22

-0.24 (-1.30%)

, JPM

JPMorgan

$90.89

-0.31 (-0.34%)

12:30
07/22/17
07/22
12:30
07/22/17
12:30
Periodicals
Deutsche Bank, JPMorgan to pay $148M to end yen Libor litigation, Reuters says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$18.22

-0.24 (-1.30%)

JPM

JPMorgan

$90.89

-0.31 (-0.34%)

C

Citi

$66.00

-0.36 (-0.54%)

HSBC

HSBC

$47.86

-0.25 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 27

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

, BMWYY

BMW

$31.52

-0.73 (-2.26%)

12:20
07/22/17
07/22
12:20
07/22/17
12:20
Periodicals
EU regulators investigating German car cartel allegations, Reuters reports »

EU antitrust regulators…

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

BMWYY

BMW

$31.52

-0.73 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

12:11
07/22/17
07/22
12:11
07/22/17
12:11
Periodicals
Seat chief sees CNG as an alternative to diesel, Reuters reports »

Seat, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$109.31

-0.53 (-0.48%)

12:03
07/22/17
07/22
12:03
07/22/17
12:03
Periodicals
Toyota to begin mass EV production in China as early as 2019, Reuters says »

Toyota Motor is likely to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$212.14

1.86 (0.88%)

, EADSY

Airbus

$20.89

-0.08 (-0.38%)

11:57
07/22/17
07/22
11:57
07/22/17
11:57
Periodicals
Boeing looking to rely on more factory automation, WSJ reports »

Boeing (BA) is cutting…

BA

Boeing

$212.14

1.86 (0.88%)

EADSY

Airbus

$20.89

-0.08 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

PUGOY

Peugeot

$21.51

-0.716 (-3.22%)

, GM

General Motors

$36.07

-0.34 (-0.93%)

11:50
07/22/17
07/22
11:50
07/22/17
11:50
Periodicals
Open defends employee leases inclusion in sales figures, Reuters reports »

Opel, which is being…

PUGOY

Peugeot

$21.51

-0.716 (-3.22%)

GM

General Motors

$36.07

-0.34 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FB

Facebook

$164.43

-0.1 (-0.06%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

11:39
07/22/17
07/22
11:39
07/22/17
11:39
Periodicals
Facebook, Apple troubles in China no longer a surprise, NY Times says »

Facebook (FB), Apple…

FB

Facebook

$164.43

-0.1 (-0.06%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

MSFT

Microsoft

$73.79

-0.43 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 05

    Sep

  • 13

    Sep

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

10:14
07/22/17
07/22
10:14
07/22/17
10:14
Periodicals
Wells Fargo investigating information sent to attorney, Bloomberg reports »

Wells Fargo said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

COKE

Coca-Cola Bottling

$240.86

-0.94 (-0.39%)

09:51
07/22/17
07/22
09:51
07/22/17
09:51
Hot Stocks
Coca-Cola Bottling announces 25c dividend for third quarter »

Coca-Cola Bottling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.61

0.01 (0.01%)

09:41
07/22/17
07/22
09:41
07/22/17
09:41
Periodicals
Procter & Gamble finds itself 'besieged again,' Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

PG

Procter & Gamble

$88.61

0.01 (0.01%)

09:40
07/22/17
07/22
09:40
07/22/17
09:40
Periodicals
Procter & Gamble finds itself 'besieged again,' Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

DF

Dean Foods

$15.35

-0.02 (-0.13%)

09:33
07/22/17
07/22
09:33
07/22/17
09:33
Periodicals
Cheddar prices could rise further, Barron's says »

Prices for block cheddar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KR

Kroger

, FDX

FedEx

$212.51

0.63 (0.30%)

09:25
07/22/17
07/22
09:25
07/22/17
09:25
Periodicals
Issuing debt to fund pensions 'not cause for worry,' Barron's says »

Issuing debt to fund…

KR

Kroger

FDX

FedEx

$212.51

0.63 (0.30%)

DAL

Delta Air Lines

$52.26

-0.57 (-1.08%)

DD

DuPont

$84.54

-0.29 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SRPT

Sarepta

$43.41

2.48 (6.06%)

09:14
07/22/17
07/22
09:14
07/22/17
09:14
Periodicals
Upbeat sales news, guidance boost lift Sarepta shares, Barron's reports »

Sarepta's shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

, SHLD

Sears

$8.83

-0.77 (-8.02%)

09:09
07/22/17
07/22
09:09
07/22/17
09:09
Periodicals
Nothing is 'Amazon-proof,' Barron's says »

Amazon's (AMZN) deal…

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

SHLD

Sears

$8.83

-0.77 (-8.02%)

HD

Home Depot

$146.65

-0.38 (-0.26%)

LOW

Lowe's

$73.84

1.28 (1.76%)

BBY

Best Buy

$54.14

0.18 (0.33%)

M

Macy's

$23.36

0.29 (1.26%)

KSS

Kohl's

$40.46

0.47 (1.18%)

ORLY

O'Reilly Automotive

$188.19

-0.5 (-0.26%)

AAP

Advance Auto Parts

$105.27

2.04 (1.98%)

WFM

Whole Foods

$41.71

-0.05 (-0.12%)

KR

Kroger

COST

Costco

$150.44

-0.55 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 15

    Aug

  • 23

    Aug

  • 29

    Aug

BA

Boeing

$212.14

1.86 (0.88%)

, LMT

Lockheed Martin

$289.12

-0.55 (-0.19%)

08:58
07/22/17
07/22
08:58
07/22/17
08:58
Periodicals
Aviation, defense stocks have 'juicy yields,' Barron's says »

Some aerospace and…

BA

Boeing

$212.14

1.86 (0.88%)

LMT

Lockheed Martin

$289.12

-0.55 (-0.19%)

UTX

United Technologies

$123.49

1.04 (0.85%)

RTN

Raytheon

$169.37

0.59 (0.35%)

LLL

L3 Technologies

$176.62

-1.1 (-0.62%)

GD

General Dynamics

$204.55

2.15 (1.06%)

NOC

Northrop Grumman

$265.30

0.53 (0.20%)

COL

Rockwell Collins

$109.31

-0.04 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 28

    Jul

  • 15

    Aug

  • 23

    Aug

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

, GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

08:50
07/22/17
07/22
08:50
07/22/17
08:50
Periodicals
Amazon, others could be threat to fiberoptic markers, Barron's says »

Amazon.com (AMZN),…

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

GOOG

Alphabet

$972.92

4.77 (0.49%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

FB

Facebook

$164.43

-0.1 (-0.06%)

AAOI

Applied Optoelectronics

$89.95

1.15 (1.30%)

LITE

Lumentum

$63.35

2.9 (4.80%)

OCLR

Oclaro

$9.90

0.04 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

  • 03

    Aug

  • 05

    Sep

  • 13

    Sep

  • 13

    Sep

NKE

Nike

$59.95

0.85 (1.44%)

, FB

Facebook

$164.43

-0.1 (-0.06%)

08:28
07/22/17
07/22
08:28
07/22/17
08:28
Periodicals
AllianceBernstein's Caruso sees EPS as 'poor' report card, Barron's says »

Frank Caruso, the chief…

NKE

Nike

$59.95

0.85 (1.44%)

FB

Facebook

$164.43

-0.1 (-0.06%)

ISRG

Intuitive Surgical

$927.47

-44.26 (-4.55%)

ANET

Arista Networks

$152.92

-3.88 (-2.47%)

AB

AllianceBernstein

$24.75

0.1 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

  • 16

    Aug

  • 17

    Aug

  • 21

    Aug

  • 13

    Sep

FLEX

Flex

$16.74

-0.07 (-0.42%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

07:53
07/22/17
07/22
07:53
07/22/17
07:53
Periodicals
Flex could rise 25% in a year, Barron's says »

Flex (FLEX) is using…

FLEX

Flex

$16.74

-0.07 (-0.42%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

LNVGY

Lenovo

$12.63

0.18 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

LUK

Leucadia

$26.45

0.03 (0.11%)

07:46
07/22/17
07/22
07:46
07/22/17
07:46
Periodicals
Leucadia shareholders to 'finally' see reward, Barron's says »

Five years after Leucadia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$46.59

0.08 (0.17%)

07:39
07/22/17
07/22
07:39
07/22/17
07:39
Periodicals
Morgan Stanley CEO would not kill off Dodd-Frank, Barron's reports »

Morgan Stanley CEO James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$46.59

0.08 (0.17%)

, JPM

JPMorgan

$90.89

-0.31 (-0.34%)

07:34
07/22/17
07/22
07:34
07/22/17
07:34
Periodicals
Big bank profits could be lifted 30% by deregulation, Barron's says »

While a major overhaul is…

MS

Morgan Stanley

$46.59

0.08 (0.17%)

JPM

JPMorgan

$90.89

-0.31 (-0.34%)

GS

Goldman Sachs

$220.18

-2.12 (-0.95%)

C

Citi

$66.00

-0.36 (-0.54%)

STT

State Street

$90.99

0.12 (0.13%)

BK

BNY Mellon

$53.36

-0.55 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 12

    Oct

  • 17

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

BCC

Boise Cascade

$29.35

0.4 (1.38%)

, CAT

Caterpillar

$106.59

-0.73 (-0.68%)

07:19
07/22/17
07/22
07:19
07/22/17
07:19
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

BCC

Boise Cascade

$29.35

0.4 (1.38%)

CAT

Caterpillar

$106.59

-0.73 (-0.68%)

CPB

Campbell Soup

$52.00

0.08 (0.15%)

LVB

Steinway Musical

GLW

Corning

$31.85

0.14 (0.44%)

MRK

Merck

$62.63

-0.31 (-0.49%)

PFE

Pfizer

$33.48

-0.06 (-0.18%)

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

AET

Aetna

$156.31

0.58 (0.37%)

ANTM

Anthem

$190.65

-0.04 (-0.02%)

CNC

Centene

$84.73

-0.67 (-0.78%)

CI

Cigna

$174.23

-0.26 (-0.15%)

HNT

Health Net

HUM

Humana

$235.92

0.09 (0.04%)

MOH

Molina Healthcare

$71.15

-0.9 (-1.25%)

UNH

UnitedHealth

$191.78

0.28 (0.15%)

WCG

WellCare

$183.87

0.1 (0.05%)

X

U.S. Steel

$23.68

-0.47 (-1.95%)

STLD

Steel Dynamics

$37.51

-0.18 (-0.48%)

NUE

Nucor

$60.23

0.31 (0.52%)

CYH

Community Health

$9.27

0.01 (0.11%)

HCA

HCA Holdings

$85.73

-0.03 (-0.03%)

LPNT

LifePoint

$65.35

-0.15 (-0.23%)

THC

Tenet

$20.65

-0.02 (-0.10%)

UHS

Universal Health

$124.42

-0.58 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 28

    Jul

  • 30

    Jul

  • 01

    Aug

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 02

    Aug

  • 02

    Aug

  • 03

    Aug

  • 03

    Aug

  • 04

    Aug

  • 04

    Aug

  • 08

    Aug

  • 14

    Aug

  • 23

    Aug

  • 27

    Aug

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

MET

MetLife

$54.65

0.07 (0.13%)

18:20
07/21/17
07/21
18:20
07/21/17
18:20
Periodicals
U.S. regulators to go over MetLife suit at July 28 meeting, Reuters says »

Leaders at the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 14

    Aug

  • 15

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.